Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP) (RISE-IIP)

Status

Closed

DZG

DZL

Start date

06/04/2014

Parameters

Inclusion criteria
  • Riociguat in IIP associated PH
Exclusion criteria
  • other etiologies of PH